# Altimmune, Inc.: Form 8-K, filed Dec 11, 2024

- Company: [Altimmune, Inc.](/companies/alt.md) (CIK 1326190)
- Form: 8-K
- Filed: 2024-12-11
- Accepted by EDGAR: Dec 11, 2024, 17:19 ET
- Period: 2024-11-15
- Accession: 0001326190-24-000053
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1326190/000132619024000053/alt-20241115x8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1326190/000132619024000053/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1326190/000132619024000053/alt-20241115x8k.htm

Filed Dec 11, 2024.
Source: SEC EDGAR, the filing index for accession 0001326190-24-000053. Last ingested by Listed: Nov 14, 2026, 20:51 ET. No prices; not investment advice.
